BSE · CHOKSI.BO
Choksi Asia Limited
₹212.95+₹1.05 (+0.5%)
Choksi Asia Limited’s quoted price sits in the upper half of its reported 52-week range, 20.08% below the high.
Loading market information…
BSE · KMSMEDI.BO · INR
Stock price, dividends
Quote as of May 15, 2026, 02:49 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
KMS Medisurgi Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
KMS Medisurgi Limited’s forward annual dividend is ₹0.05 per share, paid annual. The forward yield is 0.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
KMS Medisurgi Limited primarily manufactures medical and surgical apparatus. The company also specializes in the commercialization and distribution of a diverse range of healthcare products, including various medical instruments, single-use surgical items, hemostats, surgical systems, and specialized equipment for fields such as radiology, oncology, diagnostics, cardiology, critical care, urology, and scientific research. This enterprise was established by Gaurang Prataprai Kanakia on March 25, 1999, and maintains its corporate headquarters in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
₹212.95+₹1.05 (+0.5%)
Choksi Asia Limited’s quoted price sits in the upper half of its reported 52-week range, 20.08% below the high.
₹49.18+₹0.19 (+0.39%)
Veerhealth Care Limited’s quoted price sits in the upper half of its reported 52-week range, 5.42% below the high.
₹43.45-₹0.56 (-1.27%)
Medinova Diagnostic Services Limited’s quoted price sits in the upper half of its reported 52-week range, 5.54% below the high.
₹33.00-₹1.40 (-4.07%)
ANG Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 33.59% below the high.
₹143.00-₹6.95 (-4.63%)
Crestchem Limited’s quoted price sits in the upper half of its reported 52-week range, 22.7% below the high.
₹35.01-₹0.30 (-0.85%)
Sandu Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 29.98% below the high.
₹41.35-₹1.60 (-3.73%)
Gujarat Terce Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.3% below the high.
₹59.00₹0.00 (0.0%)
GKB Ophthalmics Limited’s quoted price sits in the lower half of its reported 52-week range, 23.28% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
